An impressive track record in conducting over 1500 bio-studies since inception, an organization driven by values and peopled by motivated professionals, have stood Lotus Labs in good stead.

Quite naturally, Lotus Labs has received recognition and accolades for the impressive strides made in its journey.

While Lotus Labs is a recipient of the National Accreditation for its Medical Diagnostic Services, the facilities are approved by the Drug Controller General of India.

Lotus Labs has signed an MOU with St. John’s Academy of Health Sciences, Bangalore - a 1200 bed multi-specialty hospital, among India’s leading medical institutions - for conducting Phase I, II and III trials.

The facilities at Lotus Labs are approved by ANVISA, Brazil and inspected by USFDA, EU (French & Austria), WHO, MCC South Africa & Zimbabwe and regulatory agency of Turkey.

Many of Lotus Labs’ submission studies have been approved by USFDA, WHO, EU, Canada and ANVISA. Lotus submission studies have been submitted to more than 45 countries across the globe.

Lotus Labs has been approved by the Ministry of Health, Israel for conducting studies for submission to the Israel regulatory body.